Clinical Assessment Glossary

A validated 9-item self-report screening tool used to assess the severity of depression. Each item corresponds to one of the DSM-5 criteria for major depressive disorder. Scores range from 0-27, with higher scores indicating more severe depression. The PHQ-9 is widely used in primary care, behavioral health settings, and research for initial screening, treatment monitoring, and outcomes measurement.

A brief, validated 7-item self-report questionnaire used to screen for and measure the severity of generalized anxiety disorder. Scores range from 0-21, with cutoff scores of 5, 10, and 15 representing mild, moderate, and severe anxiety respectively. The GAD-7 is commonly used alongside the PHQ-9 for comprehensive mental health screening.

A 10-item screening tool developed by the World Health Organization (WHO) to identify individuals with hazardous or harmful alcohol consumption patterns. The AUDIT screens for the full spectrum of alcohol use, from low-risk drinking to alcohol dependence. Scores range from 0-40, with scores of 8 or higher suggesting hazardous or harmful alcohol use.

A 10-item self-report instrument designed to screen for drug use problems excluding alcohol and tobacco. The DAST-10 provides a quantitative index of the degree of consequences related to drug abuse. Scores range from 0-10, with higher scores indicating more severe drug-related problems.

A 28-item self-report questionnaire adapted from the Eating Disorder Examination (EDE) interview. The EDE-Q assesses eating disorder psychopathology over the past 28 days across four subscales: Restraint, Eating Concern, Shape Concern, and Weight Concern. It is widely used for eating disorder screening, diagnosis support, and treatment outcome monitoring.

A 20-item self-report measure that assesses the presence and severity of PTSD symptoms as defined by DSM-5 criteria. The PCL-5 covers all four PTSD symptom clusters: intrusion, avoidance, negative alterations in cognition and mood, and alterations in arousal and reactivity. Scores range from 0-80, with a cutoff of 31-33 typically used for probable PTSD.

A structured interview and screening tool that assesses suicidal ideation and behavior. The C-SSRS distinguishes between different types of suicidal ideation (passive vs. active, with or without plan/intent) and documents actual suicide attempts or preparatory behaviors. It is FDA-endorsed and widely used for suicide risk assessment in clinical and research settings.

A 15-item screening instrument designed to identify individuals who may have bipolar spectrum disorders. A positive screen requires endorsing 7 or more symptoms, having symptoms occur together during the same period, and experiencing moderate-to-serious functional problems. The MDQ helps differentiate unipolar depression from bipolar depression.

An 18-item self-report measure that assesses symptoms of obsessive-compulsive disorder (OCD). The OCI-R covers six subscales: Washing, Checking, Ordering, Obsessing, Hoarding, and Neutralizing. Scores range from 0-72, with a cutoff of 21 typically used to indicate clinically significant OCD symptoms.

Patient-Reported Outcomes Measurement Information System (PROMIS) is a set of NIH-developed measures that assess physical, mental, and social health. PROMIS uses nationally normed T-scores with a mean of 50 and standard deviation of 10, allowing for easy interpretation and comparison across conditions. Common measures include Global Health, Sleep Disturbance, Depression, and Anxiety.

Measurable changes in a patient's health status, symptoms, functioning, or quality of life that result from healthcare interventions. In behavioral health, clinical outcomes often include symptom reduction, improved functioning, quality of life improvements, and treatment response rates. Tracking clinical outcomes is essential for evidence-based practice and demonstrating treatment effectiveness.

A clinical practice that involves the systematic use of standardized assessment tools to monitor patient progress and inform treatment decisions. MBC has been shown to improve treatment outcomes by enabling clinicians to identify patients who are not responding to treatment and adjust interventions accordingly. It is considered a best practice in behavioral health care.

A meaningful improvement in symptoms or functioning following treatment intervention. In depression treatment, for example, a treatment response is typically defined as a 50% or greater reduction in PHQ-9 score from baseline. Treatment response rates are key metrics for evaluating the effectiveness of interventions.

A state in which symptoms have decreased to a level below the clinical threshold for diagnosis. In depression, remission is typically defined as a PHQ-9 score of less than 5, indicating minimal or no depressive symptoms. Achieving and maintaining remission is a primary goal of treatment.

Adherence to the Health Insurance Portability and Accountability Act, a U.S. federal law that establishes national standards for protecting sensitive patient health information. HIPAA compliance requires implementing administrative, physical, and technical safeguards to ensure the confidentiality, integrity, and availability of protected health information (PHI).

A classification of symptom intensity based on standardized assessment scores. For the PHQ-9, severity levels include minimal (0-4), mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20-27) depression. Severity levels help guide treatment intensity and clinical decision-making.

An initial measurement taken at the start of treatment to establish a reference point for tracking progress. Baseline assessments document the patient's symptom severity before intervention begins, allowing clinicians to calculate improvement over time and evaluate treatment effectiveness.

A standardized score with a mean of 50 and standard deviation of 10, based on a reference population. T-scores are used in PROMIS measures and other assessments to allow comparison of an individual's score to a normative sample. A T-score of 60, for example, indicates functioning one standard deviation worse than the average person.

A statistical method for determining whether an individual's change in scores represents a true, clinically meaningful change rather than measurement error. The RCI accounts for the reliability of the assessment instrument and helps distinguish genuine improvement from random fluctuation.

A score derived from a subset of items within a larger assessment that measures a specific dimension or symptom cluster. For example, the EDE-Q has four subscales (Restraint, Eating Concern, Shape Concern, Weight Concern) that provide more detailed information than the global score alone.

The integration of the best available research evidence with clinical expertise and patient values to guide treatment decisions. Evidence-based practice in behavioral health involves using interventions that have been scientifically validated through rigorous research, including randomized controlled trials and systematic reviews.

A treatment model that begins with the least intensive intervention appropriate for a patient's needs and increases intensity only if the initial treatment is insufficient. Stepped care optimizes resource allocation by reserving more intensive (and expensive) treatments for patients who need them, while providing efficient care for those who respond to lower-intensity interventions.

The standard care that patients would receive in a clinical setting without any experimental intervention. TAU serves as a comparison condition in clinical research to evaluate whether new treatments provide benefits beyond routine care.

The presence of two or more disorders or conditions in the same individual. Comorbidity is common in behavioral health, with many patients experiencing co-occurring depression and anxiety, substance use and mental health disorders, or eating disorders and mood disorders. Comprehensive assessment helps identify comorbid conditions that may affect treatment planning.

A healthcare delivery model that reimburses providers based on patient health outcomes rather than the volume of services delivered. In behavioral health, VBC requires clinicians to demonstrate measurable improvements in patient symptoms, functioning, and quality of life. This model incentivizes the use of validated assessments like PHQ-9 and GAD-7 to track and document patient progress over time.

The traditional healthcare payment model where providers are reimbursed for each individual service, procedure, or visit regardless of patient outcomes. In behavioral health, FFS pays per therapy session without measuring whether the patient actually improves. Major payers are transitioning away from FFS toward value-based care models that tie reimbursement to demonstrated patient outcomes.

Standardized measures used by payers and healthcare organizations to evaluate the quality of care provided. In behavioral health, quality metrics often include depression remission rates (PHQ-9 < 5), treatment response rates (50% symptom reduction), and assessment completion rates. Clinicians who track outcomes can demonstrate strong quality metrics to qualify for value-based care contracts.

A payment approach that provides incentives for high-quality, cost-efficient care. APMs include shared savings programs, bundled payments, and capitation arrangements. Medicare, Medicaid, and commercial payers are increasingly requiring behavioral health providers to participate in APMs that reward positive patient outcomes rather than service volume.

A Medicare program under MACRA that adjusts clinician payments based on performance in quality, cost, improvement activities, and promoting interoperability. Behavioral health clinicians can earn positive MIPS adjustments by tracking patient outcomes using validated measures and demonstrating quality improvement over time.

A 2015 federal law that reformed Medicare payment policies and created the Quality Payment Program, which includes MIPS and Advanced APMs. MACRA fundamentally shifted Medicare reimbursement from volume-based to value-based, requiring providers to demonstrate quality outcomes or face payment reductions.

A healthcare payment strategy that offers financial incentives to providers who meet defined performance targets. In behavioral health, P4P programs may reward clinicians for achieving high rates of depression remission, maintaining patient engagement, or demonstrating significant symptom reduction as measured by standardized assessments.

A payment model where reimbursement is directly tied to achieving specific patient outcomes rather than delivering services. For behavioral health, this means getting paid based on whether patients actually improve—measured through tools like PHQ-9, GAD-7, or other validated assessments—rather than simply billing for sessions attended.

A network of healthcare providers who share responsibility for providing coordinated care to a defined patient population and are held accountable for quality and cost outcomes. ACOs increasingly include behavioral health integration, requiring mental health providers to track and report patient outcomes using standardized measures.

An evidence-based integrated care model where behavioral health specialists work with primary care providers to treat patients with mental health conditions. CoCM requires systematic use of validated outcome measures (like PHQ-9) to track patient progress, with reimbursement tied to achieving target outcomes. Medicare has specific billing codes for CoCM services.

A standardized set of performance measures developed by NCQA (National Committee for Quality Assurance) used by health plans to evaluate healthcare quality. HEDIS includes over 90 measures across six domains of care, including behavioral health measures like depression screening (DSF), follow-up after mental health hospitalization (FUH), and antidepressant medication management (AMM). Higher HEDIS scores indicate better quality care.

A HEDIS quality measure (DSF) that tracks the percentage of patients aged 12 and older who were screened for depression using a standardized tool like PHQ-9, and if positive, received a follow-up plan documented on the date of the positive screen. This measure promotes early identification and intervention for depression.

A HEDIS quality measure that tracks the percentage of patients aged 6 and older who were hospitalized for mental illness or intentional self-harm and received a follow-up visit with a mental health provider within 7 days (and 30 days) of discharge. This measure ensures continuity of care during a critical transition period.

A HEDIS quality measure that tracks the percentage of patients aged 18 and older who were diagnosed with major depression, treated with antidepressant medication, and remained on an antidepressant for at least 84 days (Effective Acute Phase Treatment) and 180 days (Effective Continuation Phase Treatment).

A HEDIS quality measure (IET) that tracks the percentage of patients aged 13 and older with a new substance use disorder (SUD) diagnosis who initiated treatment within 14 days of diagnosis and continued engagement with two or more SUD services within 34 days of the initiation visit.

A private, non-profit organization dedicated to improving healthcare quality. NCQA develops and maintains HEDIS measures, accredits health plans, and certifies healthcare organizations. NCQA accreditation and HEDIS performance are key indicators of health plan quality for employers and consumers.